Yunchao Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yunchao Liu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Bobby Bodenheimer
2 shared publicationsHa Dong
2 shared publicationsJens Meiler
2 shared publicationsJiawei Gu
2 shared publicationsRocco Moretti
2 shared publicationsTyler Derr
2 shared publications
Latest Publications
- Open Access
Amplifying Your Social Media Presence: Personalized Influential Content Generation with LLMs
The remarkable advancements in Large Language Models (LLMs) have revolutionized the content generation process in social media, offering significant convenience in writing tasks. However, existing applications, such as sentence completion and fluency enhancement, do not fully address the complex challenges in real-world social media contexts. A prevalent goal among social media users is to increase the visibility and influence of their posts. This paper, therefore, delves into the compelling question: Can LLMs generate personalized influential content to amplify a user's presence on social media? We begin by examining prevalent techniques in content generation to assess their impact on post influence. Acknowledging the critical impact of underlying network structures in social media, which are instrumental in initiating content cascades and highly related to the influence/popularity of a post, we then inject network information into prompt for content generation to boost the post's influence. We design multiple content-centric and structure-aware prompts. The empirical experiments across LLMs validate their ability in improving the influence and draw insights on which strategies are more effective. Our code is available at https://github.com/YuyingZhao/LLM-influence-amplifier.
Open AccessAmplifying Your Social Media Presence: Personalized Influential Content Generation with LLMs
The remarkable advancements in Large Language Models (LLMs) have revolutionized the content generation process in social media, offering significant convenience in writing tasks. However, existing applications, such as sentence completion and fluency enhancement, do not fully address the complex challenges in real-world social media contexts. A prevalent goal among social media users is to increase the visibility and influence of their posts. This paper, therefore, delves into the compelling question: Can LLMs generate personalized influential content to amplify a user's presence on social media? We begin by examining prevalent techniques in content generation to assess their impact on post influence. Acknowledging the critical impact of underlying network structures in social media, which are instrumental in initiating content cascades and highly related to the influence/popularity of a post, we then inject network information into prompt for content generation to boost the post's influence. We design multiple content-centric and structure-aware prompts. The empirical experiments across LLMs validate their ability in improving the influence and draw insights on which strategies are more effective. Our code is available at https://github.com/YuyingZhao/LLM-influence-amplifier.
- Open Access
WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking
While deep learning has revolutionized computer-aided drug discovery, the AI community has predominantly focused on model innovation and placed less emphasis on establishing best benchmarking practices. We posit that without a sound model evaluation framework, the AI community's efforts cannot reach their full potential, thereby slowing the progress and transfer of innovation into real-world drug discovery. Thus, in this paper, we seek to establish a new gold standard for small molecule drug discovery benchmarking, WelQrate. Specifically, our contributions are threefold: WelQrate Dataset Collection - we introduce a meticulously curated collection of 9 datasets spanning 5 therapeutic target classes. Our hierarchical curation pipelines, designed by drug discovery experts, go beyond the primary high-throughput screen by leveraging additional confirmatory and counter screens along with rigorous domain-driven preprocessing, such as Pan-Assay Interference Compounds (PAINS) filtering, to ensure the high-quality data in the datasets; WelQrate Evaluation Framework - we propose a standardized model evaluation framework considering high-quality datasets, featurization, 3D conformation generation, evaluation metrics, and data splits, which provides a reliable benchmarking for drug discovery experts conducting real-world virtual screening; Benchmarking - we evaluate model performance through various research questions using the WelQrate dataset collection, exploring the effects of different models, dataset quality, featurization methods, and data splitting strategies on the results. In summary, we recommend adopting our proposed WelQrate as the gold standard in small molecule drug discovery benchmarking. The WelQrate dataset collection, along with the curation codes, and experimental scripts are all publicly available at WelQrate.org.
Open AccessWelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking
While deep learning has revolutionized computer-aided drug discovery, the AI community has predominantly focused on model innovation and placed less emphasis on establishing best benchmarking practices. We posit that without a sound model evaluation framework, the AI community's efforts cannot reach their full potential, thereby slowing the progress and transfer of innovation into real-world drug discovery. Thus, in this paper, we seek to establish a new gold standard for small molecule drug discovery benchmarking, WelQrate. Specifically, our contributions are threefold: WelQrate Dataset Collection - we introduce a meticulously curated collection of 9 datasets spanning 5 therapeutic target classes. Our hierarchical curation pipelines, designed by drug discovery experts, go beyond the primary high-throughput screen by leveraging additional confirmatory and counter screens along with rigorous domain-driven preprocessing, such as Pan-Assay Interference Compounds (PAINS) filtering, to ensure the high-quality data in the datasets; WelQrate Evaluation Framework - we propose a standardized model evaluation framework considering high-quality datasets, featurization, 3D conformation generation, evaluation metrics, and data splits, which provides a reliable benchmarking for drug discovery experts conducting real-world virtual screening; Benchmarking - we evaluate model performance through various research questions using the WelQrate dataset collection, exploring the effects of different models, dataset quality, featurization methods, and data splitting strategies on the results. In summary, we recommend adopting our proposed WelQrate as the gold standard in small molecule drug discovery benchmarking. The WelQrate dataset collection, along with the curation codes, and experimental scripts are all publicly available at WelQrate.org.
- Open Access
- 1 January 2024
- Published by Curran Associates, Inc. in Biophysical Journal
- p. 53222-53236
WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking
While deep learning has revolutionized computer-aided drug discovery, the AI community has predominantly focused on model innovation and placed less emphasis on establishing best benchmarking practices. We posit that without a sound model evaluation framework, the AI community’s efforts cannot reach their full potential, thereby slowing the progress and transfer of innovation into real-world drug discovery. Thus, in this paper, we seek to establish a new gold standard for small molecule drug discovery benchmarking, WelQrate. Specifically, our contributions are threefold: WelQrate Dataset Collection - we introduce a meticulously curated collection of 9 datasets spanning 5 therapeutic target classes. Our hierarchical curation pipelines, designed by drug discovery experts, go beyond the primary high-throughput screen by leveraging additional confirmatory and counter screens along with rigorous domain-driven preprocessing, such as Pan-Assay Interference Compounds (PAINS) filtering, to ensure the high-quality data in the datasets; WelQrate Evaluation Framework - we propose a standardized model evaluation framework considering high-quality datasets, featurization, 3D conformation generation, evaluation metrics, and data splits, which provides a reliable benchmarking for drug discovery experts conducting real-world virtual screening; Benchmarking - we evaluate model performance through various research questions using the WelQrate dataset collection, exploring the effects of different models, dataset quality, featurization methods, and data splitting strategies on the results. In summary, we recommend adopting our proposed WelQrate as the gold standard in small molecule drug discovery benchmarking. The WelQrate dataset collection, along with the curation codes, and experimental scripts are all publicly available at WelQrate.org.
- 1 January 2024
- Published by Curran Associates, Inc. in Biophysical Journal
- p. 53222-53236
Open AccessWelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking
While deep learning has revolutionized computer-aided drug discovery, the AI community has predominantly focused on model innovation and placed less emphasis on establishing best benchmarking practices. We posit that without a sound model evaluation framework, the AI community’s efforts cannot reach their full potential, thereby slowing the progress and transfer of innovation into real-world drug discovery. Thus, in this paper, we seek to establish a new gold standard for small molecule drug discovery benchmarking, WelQrate. Specifically, our contributions are threefold: WelQrate Dataset Collection - we introduce a meticulously curated collection of 9 datasets spanning 5 therapeutic target classes. Our hierarchical curation pipelines, designed by drug discovery experts, go beyond the primary high-throughput screen by leveraging additional confirmatory and counter screens along with rigorous domain-driven preprocessing, such as Pan-Assay Interference Compounds (PAINS) filtering, to ensure the high-quality data in the datasets; WelQrate Evaluation Framework - we propose a standardized model evaluation framework considering high-quality datasets, featurization, 3D conformation generation, evaluation metrics, and data splits, which provides a reliable benchmarking for drug discovery experts conducting real-world virtual screening; Benchmarking - we evaluate model performance through various research questions using the WelQrate dataset collection, exploring the effects of different models, dataset quality, featurization methods, and data splitting strategies on the results. In summary, we recommend adopting our proposed WelQrate as the gold standard in small molecule drug discovery benchmarking. The WelQrate dataset collection, along with the curation codes, and experimental scripts are all publicly available at WelQrate.org.